EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

A new study is the first to show that a remote cognitive assessment could help with tracking patients with cardiovascular risk. Getty Images
News | Cardiovascular Clinical Studies
Study: Cognitive Assessments Can Help Track Cardio Risk
February 8, 2022 — A new study is the first to show that a remote cognitive assessment could help with tracking patients ...
Home February 07, 2022
Home
By far the two biggest news items from January included the first pig heart transplant into a human patient at the University of Maryland Medical Center, and the FDA clearance of Novarti's inclisiran (Leqvio) twice annual dose injectable LDL lowering drug.
Feature | By Dave Fornell, DAIC Editor
Most Popular Cardiology Content in January 2022

February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

Home February 01, 2022
Home
The cardiovascular effects of long-hauler COVID in 2022
Feature | Coronavirus (COVID-19) | By Dave Fornell, DAIC Editor
What We Know About Cardiac Long-COVID Two Years Into the Pandemic

By the end of the first year of the COVID-19 pandemic, there was a clear sign that some virus patients had longer ...

Home January 23, 2022
Home
The Affera Inc. Sphere-9 pulsed field (PF) energy radiofrequency ablation system. Medtronic purchased the company in January 2022.
News | EP Lab
Medtronic to Acquire Affera to Expand Cardiac Ablation Portfolio

January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...

Home January 14, 2022
Home
EnSite X EP mapping system with EnSite Omnipolar Technology provides a 360-degree view of the heart, regardless of catheter orientation. FDA Clears New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
News | EP Lab
FDA Clears New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms

January 13, 2022 — Abbott received U.S. Food and Drug Administration (FDA) clearance for the EnSite X EP System with ...

Home January 13, 2022
Home
Khaldoun Tarakji is moving from Cleveland Clinic to Medtronic.
News | EP Lab
Khaldoun Tarakji Joins Medtronic as Vice President and Chief Medical Officer of Cardiac Ablation Solutions

January 7, 2022 — Khaldoun Tarakji, M.D., M.P.H., associate section head of cardiac electrophysiology at the Heart ...

Home January 07, 2022
Home
Stereotaxis Robotics Reduces Incidence of Silent Cerebral Embolism During AF Ablation
News | EP Lab
Stereotaxis Robotics Reduces Incidence of Silent Cerebral Embolism During AF Ablation

January 5, 2022 — Stereotaxis announced a recent publication in Frontiers in Cardiovascular Medicine titled “Atrial ...

Home January 05, 2022
Home
FDA clears Implicity algorithm to reduce the volume of false positives from Medtronic implantable loop recorders by nearly 80%
News | Remote Monitoring
FDA Clears AI-Powered ECG Analyzer for Implantable Loop Recorders

January 4, 2022 –  Remote patient monitoring and cardiac data management solutions vendor Implicity received U.S. Food ...

Home January 04, 2022
Home
The most popular stories in 2021 included several on impact of COVID-19 on cardiology, the use of the Carmat artificial heart, advances in pulsed field ablation in electrophysiology and the FDA cleanace of the first photon-counting CT scanner.
Feature
Most Popular Stories on DAIC in 2021

Here is a list of the top 25 stories in 2021 on the Diagnostic and Interventional Cardiology (DAIC) website based on ...

Home December 16, 2021
Home
When Do Children Need Pacemakers and Defibrillators? Getty Images
Feature | EP Lab
When Do Children Need Pacemakers and Defibrillators?

Children’s Hospital Los Angeles cardiologist Michael Silka, M.D., helped to pioneer the development of indications for ...

Home December 07, 2021
Home
Patient applying a Cardiac Insight Cardea SOLO monitoring device at home. The remote, physician-prescribed and patient self-applied device is worn for a specified period of monitoring time and then returned to the physician office for report creation. 
Feature | Atrial Fibrillation
Increasing Early Detection of Atrial Fibrillation Through Improved Short-Term Monitoring

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...

Home December 07, 2021
Home
Two of the most read stories in November included CMS requiring all healthcare workers to get vaccinated by Jan. 4 and the FDA clearance of the first photon-counting CT system. The new CT technology is expected to be a paradigm shift in the future of CT technology over the next decade.
Feature | By Dave Fornell, DAIC Editor
Most Popular Cardiology Technology Content in November 2021

December 3, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

Home December 03, 2021
Home
AI for Atrial Fibrillation. BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the company entered into a feasibility study with The Technion Research & Development Foundation Ltd.
News | EP Lab
BioSig Initiates AI Development With Technion to Uncover the Full Range of ECG and Intra-Cardiac Electrical Signals

November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical ...

Home November 22, 2021
Home
Videos | EP Lab
VIDEO: Advances in Electrophysiology Technology

Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...

Home November 22, 2021
Home
The FDA said the Medtronic Micra leadless pacemaker may have a higher rate of serious complications due to cardiac perforations during implant and is trying to get more information on these incidents. 
Feature | EP Lab
FDA Warns Micra Leadless Pacing System May Have Risk of Major Complications Due to Cardiac Perforations

November 18, 2021 — The U.S. Food and Drug Administration (FDA) is reminding providers about the risk of major ...

Home November 18, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now